Literature DB >> 6549141

Quantitation of prothrombin activation products in human urine.

A Bezeaud, M C Guillin.   

Abstract

Urine samples obtained from 37 normal individuals have been screened for the presence of prothrombin activation products using radioimmunoassays developed for fragment 1, fragment 2 and prothrombin derivatives bearing the thrombin region. The cross-reacting materials detected in urine were isolated by affinity chromatography on insolubilized antibodies, and analysed by SDS polyacrylamide gel electrophoresis. The only prothrombin derivatives detected were fragment 1 (37/37) and fragment 2 (22/37). The mean values of daily urinary fragment 1 and fragment 2 excretion were respectively 13.4 nM and 1.5 nM. The excretion of prothrombin derivatives has been quantitated in 14 normal pregnant women, during the third trimester of gestation. The mean values of urinary excretion were 47.2 nM per day for fragment 1 (P less than 0.005) and 6.4 nM per day for fragment 2 (P less than 0.05). The significant increase in fragment 1 and fragment 2 excretion observed in a condition known to be associated with the so-called hypercoagulable state suggest that the measurement of prothrombin derivatives in urine could be a useful tool for the non-invasive detection of thromboembolic diseases or prethrombotic states.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6549141     DOI: 10.1111/j.1365-2141.1984.tb06106.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

1.  Glycosylation of prothrombin fragment 1 governs calcium oxalate crystal nucleation and aggregation, but not crystal growth.

Authors:  Dawn Webber; Allen L Rodgers; Edward D Sturrock
Journal:  Urol Res       Date:  2007-11-07

2.  Partial factor IX protein in a pedigree with hemophilia B due to a partial gene deletion.

Authors:  G L Bray; A R Thompson
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

3.  Face-specific binding of prothrombin fragment 1 and human serum albumin to inorganic and urinary calcium oxalate monohydrate crystals.

Authors:  Alison F Cook; Phulwinder K Grover; Rosemary L Ryall
Journal:  BJU Int       Date:  2008-11-13       Impact factor: 5.588

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.